HBXIP Regulates Gastric Cancer Glucose Metabolism and Malignancy Through PI3K/AKT and p53 Signaling
Lei Qiu,Feng Lu,Lili Zhang,Gang Wang,Rui Geng,Yongchang Miao
DOI: https://doi.org/10.2147/OTT.S243250
IF: 4
2020-04-21
OncoTargets and Therapy
Abstract:Lei Qiu, 1, * Feng Lu, 1, * Lili Zhang, 2, * Gang Wang, 1 Rui Geng, 3 Yongchang Miao 1 1 Department of General Surgery, The Second People's Hospital of Lianyungang, Lianyungang, Jiangsu, People's Republic of China; 2 Emergency Department, The Second People's Hospital of Lianyungang, Lianyungang, Jiangsu, People's Republic of China; 3 School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China *These authors contributed equally to this work Correspondence: Yongchang Miao Email miaoyongchang@21cn.com Introduction: Hepatitis B X-interacting protein (HBXIP) overexpression is related to the progression of multiple cancers. However, its role in gastric cancer (GC) remains unclear. Materials and Methods: HBXIP expression was determined in human GC specimens and cell lines by quantitative polymerase chain reaction (qRT-PCR) and Western blot. The effects of HBXIP depletion or ectopic expression on GC proliferation were evaluated in vitro using the cell counting kit-8 (CCK-8), 5-ethynyl-2ʹ-deoxyuridine (EdU) incorporation, colony formation, and cell cycle assays. The in vivo effects were investigated using a mouse xenograft model. Apoptosis was evaluated by flow cytometry (in vitro) and immunohistochemistry (IHC; in vivo). Cell migration and invasion were evaluated in vitro using wound healing, transwell migration, and matrigel invasion assays; and in vivo by quantifying distant metastases from injection of GC cells in the lateral tail vein. Results: Herein, we reported that HBXIP expression was higher in GC than in normal tissues, and this high expression indicated a poorer prognosis. Gain- and loss-of-function assays showed that HBXIP promoted GC proliferation, migration, and invasion, and inhibited apoptosis. High-performance liquid chromatography (HPLC) quantification of glycolytic metabolites revealed that HBXIP promoted glucose metabolic reprogramming. Investigation of the PI3K/AKT and p53 pathways highlighted their role in this HBXIP-mediated metabolic reprogramming. Conclusion: Our results indicate that the up-regulation of HBXIP leads to GC progression by positively regulating glucose metabolism. Therefore, HBXIP is a potential target for the treatment of GC. Keywords: HBXIP, glucose metabolism, PI3K/AKT, p53, gastric cancer
oncology,biotechnology & applied microbiology